Dr Jokubas Žiburkus is an accomplished scientist and entrepreneur. In parallel to his extensive biomedical research background, he co-founded MediTaurus LLC, a company that researches and develops the highest quality hemp-based health and wellness products and invests in the most advanced technologies and talents in the emerging cannabis and medical cannabinoid markets.
In just ten months as CEO of MediTaurus, Dr. Žiburkus established production capabilities in the US and EU, co-created an extensive line of premium hemp CBD products and formulations, set up collaborations with two EU Health Science and Agricultural universities and initiated case and clinical studies on the effects of Florance™ products and formualtions on various health conditions.
Dr. Žiburkus's biomedical expertise is in neurological disorders, where much of his research efforts focused on the mechanism and novel treatments of epilepsy and Alzheimer's Disease, as well as cannabinoid actions in the brain and body. He is a neuroscientist and researcher with over 20 peer-reviewed publications and book chapters, and numerous popular literature publications. Žiburkus is an Associate Professor at the University of Houston where his research is focused on cannabinoid actions in the brain and novel treatments for neurological disorders. Žiburkus is a recipient of the Global Lithuanian Leader Award and the University of Houston’s Teaching Excellence Award. He is a recognized public speaker with a widely watched Tedx Talk entitled, “There is something you should know about epilepsy and cannabis.” Žiburkus has a proven track record of international leadership and strategic planning, and served on several boards, including Dravet Syndrome Foundation’s Scientific and Medical Advisory Board. Dr. Žiburkus completed his PhD in Louisiana State University Health Sciences Center and his postdoctoral fellowships at the Johns Hopkins University, George Mason University, and Pennsylvania State University.